Previous Close | 1.8500 |
Open | 1.8200 |
Bid | 1.8500 x 100 |
Ask | 1.9400 x 100 |
Day's Range | 1.8000 - 1.9000 |
52 Week Range | 0.6800 - 4.5800 |
Volume | |
Avg. Volume | 136,648 |
Market Cap | 55.774M |
Beta (5Y Monthly) | 1.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Discover how DarioHealth Corp (DRIO) is shaping its future with significant B2B2C growth, high gross margins, and strategic partnerships in the first quarter of 2024.
DarioHealth (DRIO) delivered earnings and revenue surprises of 66.10% and 3.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DarioHealth Corp. (NASDAQ:DRIO) Q4 2023 Earnings Call Transcript March 28, 2024 DarioHealth Corp. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.54. DRIO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the DarioHealth Fourth Quarter […]